Social Prescribing Shows Promise in Enhancing Radiation Therapy Care

Radiation therapy is a cornerstone of cancer treatment, but the emotional and social toll it takes on patients is often overlooked. Now, a growing body of opinion suggests that social prescribing—an approach that connects patients to community-based activities and support—could play a meaningful role in improving care for those undergoing radiotherapy.

What is social prescribing?

Social prescribing is not a medical treatment in the traditional sense. Instead, it involves a healthcare professional referring a patient to non-clinical services, such as gardening clubs, art workshops, exercise groups, or volunteering opportunities. The idea is simple: addressing the social, emotional, and practical needs of a patient can complement clinical care and improve overall well-being.

In the context of radiation therapy, this could mean referring a patient to a local support group, a nutrition class, or even a walking group designed for people undergoing treatment. The approach has gained traction in several countries, particularly the UK, where it is embedded in primary care. Now, experts are asking whether it should have a more formal place in oncology.

Why it matters for radiation patients

Radiation therapy is physically demanding. Patients often experience fatigue, skin irritation, and emotional distress. The treatment schedule can be gruelling—sometimes daily sessions for several weeks—which can disrupt work, family life, and social routines. This isolation can worsen anxiety and depression, which in turn may affect how well a patient tolerates treatment.

Proponents argue that social prescribing could help break this cycle. By giving patients a sense of purpose and community, it may reduce stress and improve their ability to cope with side effects. There is also evidence, albeit early, that such interventions can improve adherence to treatment plans, as patients who feel supported are more likely to attend all their sessions.

Experts call for more research

The idea is not without its challenges. Social prescribing relies on the availability of community resources, which can vary widely from one region to another. In rural areas, for example, there may be few options for patients to choose from. Coordinating between healthcare providers and community organisations also requires time and funding, which are often in short supply.

Nevertheless, the authors of the review believe the potential benefits outweigh the obstacles. They are calling for pilot programmes that test social prescribing in radiation oncology departments, with a focus on measuring outcomes such as quality of life, treatment completion rates, and patient satisfaction. They also stress that the approach should be patient-centred, with options tailored to individual needs and preferences.

What happens next?

For now, social prescribing remains an emerging concept in cancer care, but the conversation is growing. As healthcare systems look for more holistic ways to support patients, the integration of social prescribing into radiation therapy pathways could become a reality in the coming years. The next step is to move from theory to practice, with well-designed studies and real-world implementation.